| Macrophage subpopulations in systemic lupus erythematosus J Orme, C Mohan Discovery medicine 13 (69), 151-158, 2012 | 109 | 2012 |
| Heightened Cleavage of Axl Receptor Tyrosine Kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE JJ Orme, Y Du, K Vanarsa, J Mayeux, L Li, A Mutwally, C Arriens, S Min, ... Clinical Immunology 169, 58-68, 2016 | 90 | 2016 |
| ADAM10 and ADAM17 cleave PD-L1 to mediate PD-(L) 1 inhibitor resistance JJ Orme, KA Jazieh, T Xie, S Harrington, X Liu, M Ball, B Madden, ... Oncoimmunology 9 (1), 1744980, 2020 | 87 | 2020 |
| A noncanonical AR addiction drives enzalutamide resistance in prostate cancer Y He, T Wei, Z Ye, JJ Orme, D Lin, H Sheng, L Fazli, R Jeffrey Karnes, ... Nature communications 12 (1), 1521, 2021 | 54 | 2021 |
| Macrophages and neutrophils in SLE—An online molecular catalog J Orme, C Mohan Autoimmunity reviews 11 (5), 365-372, 2012 | 51 | 2012 |
| Therapeutic plasma exchange clears circulating soluble PD-L1 and PD-L1-positive extracellular vesicles JJ Orme, EAL Enninga, F Lucien-Matteoni, H Dale, E Burgstaler, ... Journal for ImmunoTherapy of Cancer 8 (2), 2020 | 40 | 2020 |
| Intra-articular nuclear factor-κB blockade ameliorates collagen-induced arthritis in mice by eliciting regulatory T cells and macrophages SY Min, M Yan, Y Du, T Wu, E Khobahy, SR Kwon, V Taneja, ... Clinical & Experimental Immunology 172 (2), 217-227, 2013 | 33 | 2013 |
| Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT–Identified Oligometastatic Castration-Resistant Prostate … H Zhang, JJ Orme, F Abraha, BJ Stish, VJ Lowe, F Lucien, EJ Tryggestad, ... Clinical Cancer Research 27 (23), 6376-6383, 2021 | 23 | 2021 |
| An acetyl-histone vulnerability in PI3K/AKT inhibition-resistant cancers is targetable by both BET and HDAC inhibitors D Wu, Y Yan, T Wei, Z Ye, Y Xiao, Y Pan, JJ Orme, D Wang, L Wang, ... Cell reports 34 (7), 2021 | 22 | 2021 |
| Trends in prices of drugs used to treat metastatic non–small cell lung cancer in the US from 2015 to 2020 A Desai, C Scheckel, CJ Jensen, J Orme, C Williams, N Shah, ... JAMA Network Open 5 (1), e2144923-e2144923, 2022 | 20 | 2022 |
| Mutated SPOP E3 ligase promotes 17βHSD4 protein degradation to drive androgenesis and prostate cancer progression L Shi, Y Yan, Y He, B Yan, Y Pan, JJ Orme, J Zhang, W Xu, J Pang, ... Cancer research 81 (13), 3593-3606, 2021 | 19 | 2021 |
| A genopedia of lupus genes-lessons from gene knockouts Y Guo, J Orme, C Mohan Current Rheumatology Reviews 9 (2), 90-99, 2013 | 14 | 2013 |
| Progression-free survival at 24 months as a landmark after autologous stem cell transplant in relapsed or refractory diffuse large B-cell lymphoma AM Tun, S Maliske, Y Wang, DJ Inwards, TM Habermann, I Micallef, ... Transplantation and cellular therapy 28 (9), 610-617, 2022 | 11 | 2022 |
| Rational second-generation antiandrogen use in prostate cancer JJ Orme, LC Pagliaro, JF Quevedo, SS Park, BA Costello The oncologist 27 (2), 110-124, 2022 | 10 | 2022 |
| Radiation therapy in oligometastatic prostate cancer S Chinniah, B Stish, BA Costello, L Pagliaro, D Childs, F Quevedo, ... International Journal of Radiation Oncology* Biology* Physics 114 (4), 684-692, 2022 | 8 | 2022 |
| Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer AM Mahmoud, I Frank, JJ Orme, RR Lavoie, P Thapa, BA Costello, ... BMC urology 22 (1), 90, 2022 | 8 | 2022 |
| Leukocyte beta-catenin expression is disturbed in systemic lupus erythematosus J Orme, Y Du, K Vanarsa, T Wu, AB Satterthwaite, C Mohan Plos One 11 (8), e0161682, 2016 | 8 | 2016 |
| SETDB1 modulates degradation of phosphorylated RB and anticancer efficacy of CDK4/6 inhibitors Z Huang, X Li, B Tang, H Li, J Zhang, R Sun, J Ma, Y Pan, B Yan, Y Zhou, ... Cancer research 83 (6), 875-889, 2023 | 7 | 2023 |
| CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma G Tulchiner, A Brunner, M Schmidinger, N Staudacher, JJ Orme, ... Bju International 128 (1), 29, 2021 | 7 | 2021 |
| Microenvironment-mediated resistance to anti-androgen therapy JJ Orme, H Huang Cancer cell 38 (2), 155-157, 2020 | 7 | 2020 |
Haidong Dong, MD, PhD.Professor of Immunology, Mayo ClinicVerified email at mayo.edu
